Starr HL, Abell J, Larish A, Lewis S, DeMuro C, Gogate J, Jamieson C, Daly E, Zaki N, Kramer M. Self-reported review of the value of esketamine in patients with treatment-resistant depression: understanding the patient experience in the STRIVE Study. Psychiatry Research. 2020 Nov;293:113376. doi: 10.1016/j.psychres.2020.113376
Chapman L, Richardson S, McLeod L, Rimm E, Cohen J. Pilot evaluation of aggregate plate waste as a measure of students' school lunch consumption. Presented at the 2019 Annual Meeting of the American Society for Nutrition; June 9, 2019. Baltimore, MD. [abstract] Curr Dev Nutr. 2019 Jun 13; 3(Suppl 1):1391-2.
Webb J, Saande CJ, Schalinske K, Rowling M. Whole egg consumption in Zucker diabetic fatty rats display a dose-dependent reduction in weight gain and total body fat, accompanied by an increase in lean body mass. Curr Dev Nutr. 2019 Jun 13;3(Suppl 1):P21-054-1. doi: 10.1093/cdn/nzz041.P21-054-19
Saande CJ, Steffes MA, Webb JL, Valentine RJ, Rowling MJ, Schalinske KL. Whole egg consumption impairs insulin sensitivity in a rat model of obesity and type 2 diabetes. Curr Dev Nutr. 2019 Mar 11;3(4):nzz015. doi: 10.1093/cdn/nzz015
Saande CJ, Coonts C, Reed CH, Hahn KE, Rowling MJ, Schalinske K. Consumption of dietary whole egg reduces cumulative body weight gain in diet-induced obese rats. Curr Dev Nutr. 2018 Nov;2(11):P23-092. doi: 10.1093/cdn/nzy050
Kohlmeier M, Dong O. CKM genetic variants and muscle vulnerability to low magnesium intake. Presented at the 2018 American Society for Nutrition Annual Meeting; June 11, 2018. Boston, MA. [abstract] Curr Dev Nutr. 2018 Jun 28; 2(11). doi: 10.1093/cdn/nzy044
Dong OM, Suzuki O, Howard R, Jamieson K, Pointer M, Kohlmeier M, Wiltshire T. Characterizing the genetics of salt sensitivity: a cost-efficient assay in development. Poster presented at the 2018 American Society for Nutrition Annual Meeting; June 10, 2018. Boston, MA. [abstract] Curr Dev Nutr. 2018; 2(11).
Wollschlaeger BA, Willson TM, Montejano LB, Ronquest NA, Nadipelli VR. Characteristics and treatment patterns of US commercially insured and Medicaid patients with opioid dependence or abuse. J Opioid Manag. 2017 Jul;13(4):207-20. doi: 10.5055/jom.2017.0389
Ronquest N, Wollschlaeger B, Montejano L, Wilson T, Nadipelli V. Characteristics and treatment patterns of US medicaid patients with opioid use disorder. Poster presented at the 2016 International Conference on Opioids Conference; June 2016. Boston, MA. [abstract] J Opioid Manag. 2016 May; 12(3):227.
Saigi N, Espelt A, Folch C, Sarasa-Renedo A, Castellano Y, Majo X, Merono M, Brugal MT, Casabona J, REDAN Group. Differences in illegal drug consumption between native and immigrants in a large sample of injected drug users in Catalonia (Spain). Adicciones. 2014;26(1):69-76. doi: 10.20882/adicciones.136
Hong J, Reed C, Novick D, Haro JM, Aguado J. Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study. Psychiatry Research. 2011 Nov 30;190(1):110-4.
Hauber AB, Fleischmann J, Lothgren M, Wilson M, Lam A, Dubois D, Sabatowski R. Economic evaluation of OROS hydromorphone for chronic pain: a Pan-European perspective. J Opioid Manag. 2011 Jul 1;7(4):287-96.
Amin RP, Hamadeh HK, Bushel PR, Bennett L, Afshari CA, Paules RS. Genomic interrogation of mechanism(s) underlying cellular responses to toxicants. Toxicology. 2002 Dec 27;181-182:555-63.